Intelligence / Healthtech & medtech market map / Clinical and regulatory support services / Clinical evidence and trial services / Medical-device and diagnostic pre-market clinical evidence
Medical-device and diagnostic pre-market clinical evidence
Medical-device and in-vitro-diagnostic vendors requiring pre-market trial design, patient and site management, monitoring, data management and submission-ready evidence for regulatory authorization, clearance or a new indication.
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Medical-device and diagnostic vendors
- Buying centre
- Regulatory affairs, clinical and medical affairs, R&D, procurement
- Regulatory authorization or clearance deadline
- Launch in a new jurisdiction
- New indication or intended-use expansion
- Major design change requiring new clinical data
- Limited access to qualified sites and investigators
- Manual and siloed trial-data processes
- Incomplete or inaccurate regulatory data
- Fragmentation across monitoring, data management and regulatory preparation
How this was sized
$2.1B · 2024 · Proxy
Published device regulatory-affairs outsourcing revenue of $2.1B in 2024 is used as a proxy because no source isolates device and diagnostic clinical-evidence services alone. The category includes broader regulatory work and therefore is not a direct measurement of this niche. The source gives a forecast of $8.1B in 2031 and annual growth of 6%-7%; it also reports a higher $4.6B figure for 2021, further limiting confidence in comparability. Sources [4] supports the stated data-quality, manual-process and siloed-workflow pains.
- Medtech Outsourcing and Software Market Size (2026)
askdona.com · 2026-10-31 - 2025 Medtech Regulatory Affairs Benchmark - veeva.com
veeva.com · 2025-07-15
Alongside it in Clinical evidence and trial services
// Sell into Medical-device and diagnostic pre-market clinical evidence